| Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ... Cancer cell 22 (4), 425-437, 2012 | 1965 | 2012 |
| IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 … P Paschka, RF Schlenk, VI Gaidzik, M Habdank, J Kroenke, L Bullinger, ... Journal of clinical oncology 28 (22), 3636-3643, 2010 | 1007 | 2010 |
| The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML S Kayser, K Doehner, J Krauter, CH Koehne, HA Horst, G Held, ... Blood, The Journal of the American Society of Hematology 117 (7), 2137-2145, 2011 | 521 | 2011 |
| Circulating microRNAs in plasma as early detection markers for breast cancer K Cuk, M Zucknick, J Heil, D Madhavan, S Schott, A Turchinovich, D Arlt, ... International journal of cancer 132 (7), 1602-1612, 2013 | 321 | 2013 |
| Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse … K Wagner, F Damm, G Göhring, K Görlich, M Heuser, I Schäfer, ... Journal of clinical oncology 28 (14), 2356-2364, 2010 | 314 | 2010 |
| Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer D Madhavan, M Zucknick, M Wallwiener, K Cuk, C Modugno, M Scharpff, ... Clinical Cancer Research 18 (21), 5972-5982, 2012 | 299 | 2012 |
| Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ... Nature communications 10 (1), 1-17, 2019 | 287 | 2019 |
| Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer D Brocks, Y Assenov, S Minner, O Bogatyrova, R Simon, C Koop, ... Cell reports 8 (3), 798-806, 2014 | 269 | 2014 |
| Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, ... British journal of cancer 109 (10), 2665-2674, 2013 | 262 | 2013 |
| Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies S Kayser, M Zucknick, K Doehner, J Krauter, CH Koehne, HA Horst, ... Blood, The Journal of the American Society of Hematology 119 (2), 551-558, 2012 | 198 | 2012 |
| Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis D Madhavan, M Wallwiener, K Bents, M Zucknick, J Nees, S Schott, K Cuk, ... Breast cancer research and treatment 146, 163-174, 2014 | 194 | 2014 |
| Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-kB A Garding, N Bhattacharya, R Claus, M Ruppel, C Tschuch, K Filarsky, ... PLoS genetics 9 (4), e1003373, 2013 | 173 | 2013 |
| Plasma microRNA panel for minimally invasive detection of breast cancer K Cuk, M Zucknick, D Madhavan, S Schott, M Golatta, J Heil, F Marme, ... PloS one 8 (10), e76729, 2013 | 162 | 2013 |
| Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia CC Oakes, R Claus, L Gu, Y Assenov, J Hüllein, M Zucknick, M Bieg, ... Cancer discovery 4 (3), 348-361, 2014 | 161 | 2014 |
| Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia C Baer, R Claus, LP Frenzel, M Zucknick, YJ Park, L Gu, D Weichenhan, ... Cancer research 72 (15), 3775-3785, 2012 | 159 | 2012 |
| Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis D Madhavan, C Peng, M Wallwiener, M Zucknick, J Nees, S Schott, ... Carcinogenesis 37 (5), 461-470, 2016 | 158 | 2016 |
| Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia R Claus, DM Lucas, S Stilgenbauer, AS Ruppert, L Yu, M Zucknick, ... Journal of Clinical Oncology 30 (20), 2483-2491, 2012 | 144 | 2012 |
| Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients R Sharma, JM Hoskins, LP Rivory, M Zucknick, R London, C Liddle, ... Clinical cancer research 14 (3), 817-825, 2008 | 136 | 2008 |
| Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway B Goeppert, C Konermann, CR Schmidt, O Bogatyrova, L Geiselhart, ... Hepatology 59 (2), 544-554, 2014 | 132 | 2014 |
| Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome C Olk-Batz, AR Poetsch, P Nöllke, R Claus, M Zucknick, I Sandrock, ... Blood, The Journal of the American Society of Hematology 117 (18), 4871-4880, 2011 | 121 | 2011 |
Axel BennerDKFZ Heidelberg在 dkfz-heidelberg.de 的电子邮件经过验证
